Table 3

Univariable linear regression

Variable	b	(95% CI)	P value
Cirrhosis	−0.49	(−0.67 to −0.32)	<0.001
Age, per 10 years	−0.05	(−0.09 to −0.01)	0.029
Female sex	0.02	(−0.12 to 0.16)	0.78
Diabetes	−0.02	(−0.15 to 0.12)	0.83
Insulin-requiring diabetes	−0.05	(−0.21 to 0.11)	0.52
Body mass index, per 5 kg/m²	−0.02	(−0.07 to 0.02)	0.27
Chronic kidney disease	−0.08	(−0.23 to 0.06)	0.27
Active cancer	−0.14	(−0.33 to 0.04)	0.12
High malnutrition risk*	0.14	(−0.04 to 0.31)	0.13
Sepsis	−0.09	(−0.29 to 0.11)	0.38
Creatinine, per log increase	0.02	(−0.01 to 0.04)	0.17
Acute kidney injury	0.00	(−0.14 to 0.13)	0.97
Beta-blockers
Cardioselective	0.10	(−0.05 to 0.24)	0.41
Non-selective	0.04	(−0.32 to 0.41)
Pretreatment K⁺	0.62	(0.50 to 0.74)	<0.001
Pretreatment HCO₃⁻	0.01	(−0.01 to 0.02)	0.31
Pretreatment pH	0.02	(−0.86 to 0.82)	0.96
Repeat insulin-glucose	−0.08	(−0.25 to 0.09)	0.38
Sodium polystyrene sulfonate	−0.22	(−0.36 to −0.08)	0.002
Salbutamol	0.26	(0.05 to 0.47)	0.021
5 mg	0.14	(−0.11 to 0.40)
10–20 mg	0.42	(0.09 to 0.74)
Sodium bicarbonate
<100 mmol	−0.10	(−0.40 to 0.21)	0.002
≥100 mmol	0.55	(0.24 to 0.85)
Intravenous furosemide	−0.12	(−0.37 to 0.14)	0.37